Page last updated: 2024-11-06

mitomycin and Brain Hemorrhage

mitomycin has been researched along with Brain Hemorrhage in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"A 50-year-old woman treated for breast cancer with mitomycin C developed severe hypertension, followed by deep coma 3 days later."3.71Hemolytic uremic syndrome with intracranial hemorrhage following mitomycin C administration. ( Katayama, Y; Kitamura, H; Komaba, Y; Nishiyama, Y, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishiyama, Y1
Komaba, Y1
Kitamura, H1
Katayama, Y1

Other Studies

1 other study available for mitomycin and Brain Hemorrhage

ArticleYear
Hemolytic uremic syndrome with intracranial hemorrhage following mitomycin C administration.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:3

    Topics: Alkylating Agents; Brain; Breast Neoplasms; Female; Hemolytic-Uremic Syndrome; Humans; Intracranial

2001